Durkin, Louis

Durkin, Louis was paid $869K by Medicaid between Jan 2018 and Oct 2024, across 9 billing codes. Its largest line is 99283, emergency room visit (moderate) — 36% of everything it billed.

33Billing provider infoDURKIN, LOUIS
SPRINGFIELD, MA 01104

33aNPI1699784025assigned 08/05/2006

33bProvider typeEmergency Medicine Physician

28Total paid$869K

24GClaims14,722

24DCodes billed9

24AFirst – last monthJan 2018 – Oct 2024

Compared with peers

Next to other Emergency Medicine Physician providers in Massachusetts

Rank by total paid#24 of 618

Median peer was paid$8K

This provider vs. median105×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	3,651	$207K
2019	6,643	$382K
2020	3,141	$201K
2021	776	$51K
2022	181	$10K
2023	170	$10K
2024incomplete	160	$8K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	36%	6,724	6,597	$315K
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	27%	2,636	2,611	$234K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	9.9%	1,472	668	$86K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	9.4%	619	614	$82K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	8.7%	1,590	696	$76K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	7.4%	1,086	474	$65K
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.1%	323	319	$10K
84460		<1%	136	135	$719.29
84450		<1%	136	135	$703.31

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.